ERBB2 and breast carcinoma: The data showed that higher expression of IGF2 and/or lower expression of miR-98 were significantly correlated with poor overall survival (OS), recurrence free survival (RFS) and distant metastasis-free survival (DMFS) in HER2-positive breast cancer (Figure 4C).